A clinical evaluation of novobiocin in amebiasis.
D000562:Amebiasis / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D004404:Dysentery, Amebic; D009675:Novobiocin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D009675:Novobiocin
AMEBIASIS/therapy; ANTIBIOTICS/therapeutic use